Crispr Therapeutics shares tumble after significant earnings miss
Jason E. Dymbort, General Counsel and Secretary at First Solar Inc . (NASDAQ:FSLR), recently executed several stock transactions, according to a Form 4 filing with the Securities and Exchange Commission. On March 7, Dymbort sold 320 shares of First Solar common stock at an average price of $132.96 per share, totaling approximately $42,547. The transaction occurs as First Solar trades near its 52-week low of $124.96, with the stock down about 33% over the past six months.
Earlier, on March 6, Dymbort engaged in a series of transactions involving restricted stock units. These included acquisitions of 760, 471, and 757 shares, all at no cost, as part of the company’s annual equity grants. Additionally, he disposed of 528 shares at $131.13 per share to cover tax withholding obligations, amounting to $69,236. According to InvestingPro analysis, First Solar maintains strong financial health with a "GREAT" overall score, and the stock appears undervalued based on Fair Value calculations.
Following these transactions, Dymbort’s direct holdings in First Solar stand at 21,782 shares. For deeper insights into First Solar’s insider trading patterns and comprehensive valuation metrics, including 14 additional ProTips and detailed financial analysis, check out the full research report on InvestingPro.
In other recent news, First Solar has announced a partnership with Everstream Analytics to enhance its supply chain resilience and visibility. This collaboration aims to provide First Solar with real-time insights and risk management tools to address potential disruptions. In financial updates, Barclays (LON:BARC) revised its price target for First Solar to $236, maintaining an Overweight rating. Analyst Christine Cho noted the company’s 2025 revenue guidance relies on its Indian operations running near full capacity, while facilities in Malaysia and Vietnam are expected to underperform.
Similarly, Mizuho (NYSE:MFG) Securities adjusted its price target to $252, continuing an Outperform rating. The firm highlighted First Solar’s U.S. production progress and minor gross margin percentage reductions. UBS also reduced its target to $285, maintaining a Buy rating, citing a positive outlook on First Solar’s U.S. production ramp-up and competitive edge in domestic manufacturing. RBC Capital lowered its price target to $251, retaining an Outperform rating due to challenges impacting the company’s operational efficiency and gross margins.
First Solar’s fourth-quarter results showed gross bookings of approximately 5.1 gigawatts in the U.S. market, with an average selling price of $0.309 per watt. Despite some international demand concerns, analysts maintain confidence in the company’s U.S. operations. These developments reflect the ongoing adjustments and strategic moves by First Solar in response to both domestic and international market conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.